Fortrea has acquired Applied Clinical Trials for $45.0 million, a move that integrates a leading resource for clinical trial professionals into Fortrea's operations. Applied Clinical Trials is widely recognized as an authoritative, peer-reviewed resource and thought leader for the global community involved in designing, initiating, managing, conducting, and monitoring clinical trials. Its platform provides industry professionals with effective and efficient solutions to strategic and tactical challenges prevalent within the tightly regulated pharmaceutical environment.
The acquisition strengthens Fortrea's presence within the clinical research ecosystem by incorporating a respected voice and knowledge base. Applied Clinical Trials' global, peer-reviewed journal focuses on the intricate process of managing clinical trials, specifically at the intersection where pharmaceutical product developers engage with medical researchers testing new drugs. This focus offers deep insights into the operational and regulatory complexities faced by professionals in the field.
This purchase allows Fortrea to leverage Applied Clinical Trials' established reputation and content expertise. The integration is anticipated to enhance Fortrea's ability to engage with key stakeholders across the clinical trials landscape, providing a more comprehensive understanding of industry needs and trends. The combined entity is positioned to offer enriched resources and solutions to professionals navigating the evolving demands of drug development and clinical research.
The unified organization will continue to serve the global clinical trials community, aiming to deliver valuable insights and practical guidance. This consolidation is expected to foster innovation and efficiency in addressing the critical challenges faced by pharmaceutical product developers and medical researchers worldwide.